TearLab Corporation

Thomas N. Davidson has been a member of our board since September 2004 and has been on the board of TLC Vision since 2002. Mr. Davidson has been Chairman of NuTech Precision Metals Inc. and Chairman of Quarry Hill Group, a private investment holding company, since 1986. NuTech Precision Metals Inc. is a manufacturer of high performance metal fabrications for aerospace and nuclear industries. Mr. Davidson is past Chairman of Hanson Chemical Inc., a supplier of specialty chemical products; General Trust, Canadian Trust Co., PCL Packaging Inc., a supplier of plastic packaging; Azure Dynamics Corporation, a developer of hybrid electrical vehicle systems for commercial vehicles. He is on the board of MDC Partners, Inc. and was recognized by the Financial Post as the Canadian Entrepreneur of the year in 1979.

Dr. Adrienne Graves is President and CEO of Santen Inc., the US subsidiary of Japanese-based Santen Pharmaceutical Co., Ltd. She joined Santen in 1995 and served as Senior Vice President, Worldwide Clinical Development. In that role, Dr. Graves was responsible for building a global team that successfully developed prescription products in ophthalmology, obtaining three FDA approvals in less than four years. She was appointed President and CEO in 2002.

A visual scientist by training, Dr. Graves completed undergraduate work at Brown University and a Ph.D. at the University of Michigan. She completed a post-doctoral fellowship in visual neuroscience at the University of Paris and is fluent in French. Dr. Graves is the author/co-author of more than 30 scientific articles.

In addition to her role as President and CEO of Santen Incorporated, she serves as a corporate officer for Santen Pharmaceutical Co., Ltd., and serves on the board of directors for OccuLogix, Inc. She also serves on the boards of the AAO (American Academy of Ophthalmology) Foundation, the Pan-American Association of Ophthalmology, and the Corporation Committee for the Brown University Medical School. She co-founded OWL (Ophthalmic Women Leaders) with Dr. Marguerite McDonald.

Dr Richard L Lindstrom, founder and attending surgeon of Minnesota Eye Consultants and Adjunct Professor Emeritus at the University Of Minnesota Department Of Ophthalmology, is a board-certified ophthalmologist and internationally recognized leader in corneal, cataract, refractive and laser surgery. He has been at the forefront of ophthalmology's evolutionary changes throughout his career, as a recognized researcher, teacher, inventor, writer, lecturer and highly acclaimed physician and surgeon.

After graduating Magna Cum Laude from the College of Liberal Arts at the University of Minnesota, Dr Lindstrom completed his doctorate degree in medicine in 1972. He conducted research, residency and fellowship training in cornea at the University of Minnesota and affiliated hospitals and extended his anterior segment surgery fellowship training at Mary Shiels Hospital in Dallas and was a Heed Fellow in Glaucoma at University Hospital in Salt Lake City. In 1980, Dr Lindstrom returned to the University of Minnesota, where he spent ten years on the faculty of the Department of Ophthalmology, the last two as a full professor and the Harold G. Scheie Research Chair. He continues as Adjunct Professor Emeritus, Chairman of the Vision Foundation, and Associate Director of the Minnesota Lions Eye Bank at the University of Minnesota. He entered private practice in 1989, and has led the growth and expansion of Minnesota Eye Consultants serving as managing partner for 15 years.

He is medical director of Sightpath Medical which includes MSS and Laser Vision. He is also medical director of Refractec.

He is Chief Medical Editor of the USA and International editions of Ocular Surgery News, which reaches 82,000 Ophthalmologists worldwide.

Dr. Lindstrom is past President of the American Society of Cataract and Refractive Surgeons. He serves on the Executive Committee and is the Chair of the ASCRS Foundation. He is also past President of the International Society of Refractive Surgery, the International Intraocular Implant Club, and the International Refractive Surgery Club. He is the Global Education Liaison of the International Society of Refractive Surgery of the American Academy of Ophthalmology. He is Chairman and CEO of Lindstrom Restoration, a three-generation family business. He has endowed funds supporting the University of Minnesota, Department of Ophthalmology, the Eye Bank Association of America, and the University of Minnesota Tennis Team.

Dr Lindstrom holds over 35 patents in ophthalmology and has developed a number of solutions, intraocular lenses and instruments that are used in clinical practices globally. He serves on the Board of Directors of AcuFocus, Inc, TLC Vision, TearLab Corporation, Refractec, the Minnesota Medical Foundation, and Inner City Tennis.

A frequent lecturer throughout the world on cornea, cataract and refractive surgery, he has presented over 40 named lectures and keynote speeches before professional societies in the U.S. and abroad, most recently giving the Blumenthal Memorial lecture in Jerusalem, Israel, the Benedetto Strampelli Medal Lecture in Rome, Italy, and the Albrecht von Garefe-Vorlesung Innovator’s Lecture in Nuremberg, Germany, IIIC Medal Lecture in Berlin, Germany.

Dr Lindstrom serves on a number of Journal editorial boards, including JCRS, JRS, and Ophthalmic Surgery. He is the Honorary Editor-in-Chief of the U.S./Chinese Journal of Ophthalmology. He has co-edited seven books, published over 350 peer reviewed journal articles and 60 book chapters. His professional affiliations are extensive, including Liaison of the International Society of Refractive Surgery of the American Academy of Ophthalmology.

He is the recipient of numerous awards for distinguished service by national and international ophthalmology associations, including the LANS, Barraquer and the first lifetime achievement award from the International Society of Refractive Surgery in October 1995 and also was honoured with another lifetime achievement award in October 2002, the Binkhorst Lecture Award from the American Society of Cataract and Refractive Surgery, the Bausch and Lomb Lifetime Achievement Award, April 2005, Benjamin F. Boyd Humanitarian Award in August 2000, and the Paton Award and NACT from the Eye Bank Association of America.

Donald Rindell has been a member of the board of directors of TearLab Corporation since March 2006. He currently serves as Executive Director of Business Development for Amylin Pharmaceuticals, Inc., a position he has held since 2005. Prior to joining Amylin Pharmaceuticals, Inc., Mr. Rindell had a successful consulting practice, during which time he served as Acting President of Medical Device Group, Inc., an acute care and respiratory company, Vice President of Business Development of CardioNet, Inc., a “real-time” 24/7 cardiovascular monitoring company, and Vice President of Business Development of HandyLab, Inc., a molecular diagnostics and pharmacogenomics system company. His responsibilities included corporate marketing, mergers and acquisitions activities, product planning and new strategic initiatives. Prior to his consulting practice, he served as Vice President of Corporate Development & Strategic Planning of Advanced Tissues Sciences, Inc. (“ATS”), a La Jolla, California-based biotechnology company. Prior to his tenure at ATS, Mr. Rindell was the Vice President for Global Business Management of Braun/Thermoscan, a division of The Gillette Company. At Braun/Thermoscan, he played a major role in building its medical diagnostics business to achieve sales exceeding $170 million. Mr. Rindell was also employed by Hybritech, a division of Eli Lilly and Company as Executive Director of Sales and Marketing. Mr. Rindell received his B.S. degree in Economics from the College of Wooster and an M.B.A. from Pepperdine University Graduate School of Business.